Navigation
Navigation
User login
Back to top

The Haematological Malignancy Research Network provides information about leukaemias, lymphomas, myelomas, and related blood disorders. Our statistics are based on data from the UK, and use the World Health Organization’s Classification for Oncology (ICD-O-3) which currently recognises over 100 different haematological malignancy subtypes.

If you are a participant in our research, you can find more information on our patient hub, YHHN.org.

What's new?

Recent collaborations

HMRN data was used in this research

1. Epigenetic regulator genes direct lineage switching in MLL/AF4 leukaemia, Blood, July 2022

Read the research paper.

2. Genomic and microenvironmental landscape of stage I follicular lymphoma, compared to stage III/IV, Blood Advances, July 2022

Read the research paper.

New publication

We are delighted to announce a comparison cohort for the HMRN. This cohort allows us to compare the health of patients with blood cancer to similar people in the general population who are cancer-free. These comparisons are helping us find out more about how blood cancers (leukaemias, lymphomas, multiple myeloma) relate to other conditions and illnesses.  

Read all about it here.

Read the research paper: Cohort Profile Update: HMRNs UK population-based cohorts

Network members

NHS haematology staff in the HMRN clinical network can access the Members' section here (active HMRN account required)

Visit members' section